Changes in quality of life during palliative chemotherapy for solid cancer

Bang, Soo‐Mee; Park, Se Hoon; Kang, Hee Geun; Jue, Jung In; Cho, In Hee; Yun, Young Ho; Cho, Eun Kyung; Shin, Dong Bok; Lee, Jae Hoon

doi:10.1007/s00520-004-0708-0

Cited by 42 publications

(16 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The frequency of bone metastases was equal between the treatment groups. We assume this result to be an effect of the treatment as previously described [19,20].…”

Section: Discussionmentioning

confidence: 99%

Quality of life in women with metastatic breast cancer during 9 months after randomization in the TEX trial (epirubicin and paclitaxel w/o capecitabine)

Svensson

Einbeigi

Johansson

et al. 2010

Breast Cancer Res Treat

View full text Add to dashboard Cite

show abstract

“…The frequency of bone metastases was equal between the treatment groups. We assume this result to be an effect of the treatment as previously described [19,20].…”

Section: Discussionmentioning

confidence: 99%

Quality of life in women with metastatic breast cancer during 9 months after randomization in the TEX trial (epirubicin and paclitaxel w/o capecitabine)

Svensson

Einbeigi

Johansson

et al. 2010

Breast Cancer Res Treat

View full text Add to dashboard Cite

show abstract

“…Symptom scale scores of the patients with anxiety were significantly higher than the patients without anxiety ( Table 2). Bang et al (45) determined that all variables of EORTC-QoL-C30 scale scores in solid cancer patients were significantly associated with anxiety and depression. Skarstein et al proved the relationship between the HADS and the QoL-C30 in patients with different cancers.…”

Section: Discussionmentioning

confidence: 99%

Sexual satisfaction, anxiety, depression and quality of life among Turkish colorectal cancer patients [Izmir Oncology Group (IZOG) study]

Akyol¹,

Ülger²,

Alacacıoğlu³

et al. 2015

Japanese Journal of Clinical Oncology

View full text Add to dashboard Cite

Objective: Determination of psychological problems will shed light on the terms of solution and provide support to patients about these problems will ensure the patients' coherence to the treatment and will enhance the benefits they receive from treatment. In this study, we aimed to determine these psychosocial problems and the interactions with each other in colon cancer patients. Methods: In this study, 105 patients with colorectal cancer were included. The forms consist of sociodemographic features, Hospital Anxiety and Depression Scale, European Organization for Research on Treatment of Cancer Questionnaires Quality of Life-C30 and Golombok-Rust Inventory of Sexual Satisfaction questionnaires. Results: Male patients had significantly higher European Organization for Research on Treatment of Cancer Questionnaires Quality of Life-C30 function scales and global quality-of-life scores than female patients. Golombok-Rust Inventory of Sexual Satisfaction scores of female patients were significantly higher than that of male patients. European Organization for Research on Treatment of Cancer Questionnaires Quality of Life-C30 function scales and global quality-of-life scores of the patients with high depression scores were significantly lower, conversely symptom scale scores of the patients with high depression scores were significantly higher than that of the patients with low depression scores. Patients with low anxiety scores had significantly higher European Organization for Research on Treatment of Cancer Questionnaires Quality of Life-C30 function scales and global quality-of-life scores than the patients with high anxiety scores. Symptom scale scores of the patients with high anxiety scores were significantly higher than that of the patients with low anxiety scores. The scores of Golombok-Rust Inventory of Sexual Satisfaction except premature ejaculation and vaginismus were significantly higher in patients with high anxiety scores and a significant difference was determined in touch, avoidance and anorgasm. Conclusions: This study demonstrates that there is a significant association with anxiety/depression symptoms and quality-of-life scores, sexual dysfunction. Sexual dysfunction is significantly more common in patients with high anxiety and depression scores.

show abstract

“…High-dose radiation therapy in lung cancer patients actually decreased the QoL score by almost 5 points and increased dyspnea scores by 5 points 2 weeks after radiation therapy, although this decline did not persist beyond 3 months [34]. Patients with metastatic solid tumors receiving palliative chemotherapy had an improvement of 8 points in their QoL scores after several rounds of chemotherapy [35]. The most remarkable improvement in dyspnea scores has been demonstrated in patients receiving bronchoscopic intervention for malignant airway obstruction, with improvements of 9 points in the QoL scores and almost 40 points on the C30 dyspnea scale 30 days after stent placement [36].…”

Section: Discussionmentioning

confidence: 99%

The Impact of Tunneled Pleural Catheters on the Quality of Life of Patients with Malignant Pleural Effusions

Sabur

Chee²,

Stather³

et al. 2012

Respiration

View full text Add to dashboard Cite

Background: Tunneled pleural catheters (TPC) are used in the management of malignant pleural effusions (MPE), but the impact of this palliative procedure on patient quality of life (QoL) has not been well described. Objectives: To ascertain the impact of TPCs on symptoms and QoL of patients with recurrent MPE. Methods: Patients with recurrent MPE completed the EORTC QLQ-C30 and LC13 QoL questionnaires at baseline, 2 and 14 weeks; FACIT-TS-G^© treatment satisfaction surveys were completed at 14 weeks. Results: A total of 82 patients were recruited. Thirty-seven patients (37/82, 45%) died prior to their 14-week follow-up appointment. Significant improvements in dyspnea at 2 weeks were demonstrated with both dyspnea scores (LC13 baseline score 64.1, 2-week score 43.7, mean change –20.4, n = 56, p < 0.001; C30 baseline score 78.9, 2-week score 46.6, mean change –32.4, n = 68, p < 0.001), as well as with the MRC score (baseline median score 4, 2-week score 3, n = 70, p < 0.001). Global health status/QoL was also significantly improved at 2 weeks (baseline score 34.1, 2-week score 46.3, mean change 12.3, n = 68, p < 0.001). Improvements in cough, fatigue and all functional scales were noted at 2 weeks. The improvements in dyspnea and global health status/QoL were maintained to 14 weeks in surviving subjects and there was further improvement in the MRC score at 14 weeks. Patients who completed the FACIT-TS-G survey demonstrated overall satisfaction with TPC treatment. Conclusions: TPCs are associated with a significant improvement in global health status, QoL and dyspnea at the 2-week time point in patients with recurrent MPE.

show abstract

Changes in quality of life during palliative chemotherapy for solid cancer

Abstract: Palliative chemotherapy treatment in patients with solid cancer improved cancer-related symptoms, lessened anxiety and did not disturb the QOL of cancer patients.

Cited by 42 publications

References 12 publications

Quality of life in women with metastatic breast cancer during 9 months after randomization in the TEX trial (epirubicin and paclitaxel w/o capecitabine)

Quality of life in women with metastatic breast cancer during 9 months after randomization in the TEX trial (epirubicin and paclitaxel w/o capecitabine)

Sexual satisfaction, anxiety, depression and quality of life among Turkish colorectal cancer patients [Izmir Oncology Group (IZOG) study]

The Impact of Tunneled Pleural Catheters on the Quality of Life of Patients with Malignant Pleural Effusions

Contact Info

Product

Resources

About